Pfizer secures FDA approval for hot flashes drug Duavee
Pfizer has secured approval from the US Food and Drug Administration (FDA) for its new drug Duavee (conjugated estrogens/bazedoxifene) 0.45mg/20mg tablets, for treatment of hot flashes in women with menopause.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news
More News: Food and Drug Administration (FDA) | Men | Menopause | Pfizer | Pharmaceuticals | Premarin | Women